Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2006-02-005462DOI Listing

Publication Analysis

Top Keywords

misclassification amyloidosis
4
amyloidosis unwarranted
4
misclassification
1
unwarranted
1

Similar Publications

Tafamidis is the only disease-modifying therapy approved to treat patients in the United States with transthyretin amyloid cardiomyopathy (ATTR-CM), which most commonly affects patients aged ≥ 65 years. The manufacturer operates a patient assistance program (PAP) to support access to tafamidis. This study conducted Privacy Preserving Record Linking (PPRL) using Datavant tokens to match patients across Medicare prescription drug plan (PDP) and PAP databases to evaluate the impact of PAPs on treatment exposure classification, adherence, and persistence determined using Medicare PDP data alone.

View Article and Find Full Text PDF
Article Synopsis
  • Recent advances in blood markers for Alzheimer's disease detection show high accuracy, but their practicality in clinical settings remains uncertain due to the need for sensitive equipment.
  • A study of 290 participants at a specialized memory clinic revealed that plasma pTau levels were significantly higher in those with amyloid-positive results compared to amyloid-negative individuals, indicating potential for blood tests in diagnosis.
  • The automated platform demonstrated a strong capacity to accurately differentiate between amyloid-positive and amyloid-negative patients, with pTau showing the highest accuracy and a low misclassification rate, suggesting it could be a reliable diagnostic tool.
View Article and Find Full Text PDF

Deep Learning for Echo Analysis, Tracking, and Evaluation of Mitral Regurgitation (DELINEATE-MR).

Circulation

September 2024

Seymour, Paul, and Gloria Milstein Division of Cardiology, Department of Medicine, Columbia University Irving Medical Center/New York-Presbyterian Hospital, NY (A.L., G.M., E.D., T.M., M.M., A.J.E., D.K., S.H., Q.L., V.A., M. Lebehn, M. Leon, R.H., P.E., T.J.P.).

Article Synopsis
  • A novel deep learning (DL) system was developed to enhance the interpretation of transthoracic echocardiography (TTE) for assessing the severity of mitral regurgitation (MR) by integrating multiple video assessments.
  • The system was tested with a large dataset (over 61,000 TTEs) and showed high accuracy in classifying MR severity, achieving exact accuracy rates of 82% for internal and 79% for external test sets.
  • Most misclassifications occurred between none/trace and mild MR categories, and the use of multiple TTE views improved classification accuracy.
View Article and Find Full Text PDF

Background: Recently developed blood markers for Alzheimer's disease (AD) detection have high accuracy but usually require ultra-sensitive analytic tools not commonly available in clinical laboratories, and their performance in clinical practice is unknown.

Methods: We analyzed plasma samples from 290 consecutive participants that underwent lumbar puncture in routine clinical practice in a specialized memory clinic (66 cognitively unimpaired, 130 participants with mild cognitive impairment, and 94 with dementia). Participants were classified as amyloid positive (A+) or negative (A-) according to CSF Aβ/Aβ ratio.

View Article and Find Full Text PDF

Background: SPECT improves diagnostic specificity of Technetium-99m pyrophosphate (PYP) scintigraphy. Diagnostic performance of PYP data, reconstructed as either chest or cardio-focal SPECT is not known.

Methods: In this quality assurance study, blinded evaluation of PYP SPECT/CT data from 102 Caucasian patients (mean age 76 ± 11 years, 67% men) was performed by two readers.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!